Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: kathleen who wrote (362)	7/15/1998 5:27:00 PM
From: Harry D. Kramer	Respond to of 586

>> I looked over the list of companies that Aries invests in. They all seem to be be companies whose stock price will appreciate significantly if trials and FDA decisions go their way. << This statement applies to each and every biotech company (which small biotech stock wouldn't rise significantly after positive trials or FDA decisions????). And it doesn't help in analyzing Paramount's strategy and management capabilities. I think we can only try to make a judgement based on their past performance and this seems to be mediocre at best. Generally, however, I agree with you that biotech is the most difficult industry to invest. Even the pros think about it this way, and that's why biotech has gone out of fashion these days. Not enough return for the risk you take. CYPB, of course, may be one of the few exceptions, at least that's what we here are hoping.